Sintaho Pharmaceutical Ltd was established in the year of 2016 and headquartered in Chongqing China, with a grand vison of being the most trusted partner to pharmaceutical companies worldwide. We have a clear focus on developing and manufacturing highly potent and cytotoxic Active Pharmaceutical Ingredients (APIs) and CDMO services.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>MIP-PNP refers to a Molecularly Imprinted Polymer designed for selective recognition of 6-mercaptopurine (6-MP). This advanced material utilizes cross-linking polymerization with functional monomers and a porogen. The core structure relies on specific cavities matching the template molecule.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Analysis:</strong> Sensitive detection of 6-MP residues in biological fluids.</li>
<li><strong>Purification Processes:</strong> Selective extraction of 6-MP from complex reaction mixtures.</li>
<li><strong>Sensing Devices:</strong> Integration into electrochemical sensors for real-time monitoring.</li>
</ul>
<h3>Precautions</h3>
<p>Store in a cool, dry place away from direct sunlight. Handle with appropriate PPE to avoid skin contact or inhalation of dust. Ensure compatibility with organic solvents during regeneration cycles.</p>